NCT05507515View on ClinicalTrials.gov

A Phase 1 Study of ONO-2020 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

July 29, 2022

Primary Completion Date

December 24, 2023

Study Completion Date

December 24, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

ONO-2020

ONO-2020 tablets

DRUG

Placebo

Placebo tablets matching ONO-2020 tablets

Trial Locations (1)

90630

Altasciences, Cypress

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY

NCT05507515 - A Phase 1 Study of ONO-2020 in Healthy Participants | Biotech Hunter | Biotech Hunter